Jeon Min Ji, Chung Mi Sun, Kwon Hyemi, Kim Mijin, Park Suyeon, Baek Jung Hwan, Song Dong Eun, Sung Tae-Yon, Hong Suck Joon, Kim Tae Yong, Kim Won Bae, Shong Young Kee, Lee Jeong Hyun, Kim Won Gu
Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Clin Endocrinol (Oxf). 2017 Jun;86(6):845-851. doi: 10.1111/cen.13322. Epub 2017 Mar 30.
Papillary thyroid microcarcinoma (PTMC) has an excellent prognosis with an indolent disease course. However, some PTMCs have an aggressive course with lateral cervical lymph node (LCLN) metastasis or distant metastasis. This study aimed to evaluate the pre-operative features of PTMC associated with LCLN metastasis.
This retrospective cohort study with a nested, matched case-control design included 199 PTMC patients with LCLN metastasis at initial surgery (N1b group) and 196 PTMC patients without any LN metastasis or persistent disease (N0 NED group) as controls; primary tumour sizes were matched.
Compared with the N0 NED group, the N1b group was younger (<50 years) and more likely to be male (P = 0·002 and P = 0·003, respectively). On pre-operative neck ultrasonography (US), N1b group PTMCs were more commonly associated with a location in the upper lobes of the thyroid, or in the subcapsular area and microcalcifications than N0 NED group PTMCs (all P < 0·001). An increase in the number of these features was significantly associated with a higher risk of LCLN metastasis (P < 0·001). Evaluation of the clinical and pre-operative US characteristics of 26 patients with confirmed LCLN recurrence after initial treatment of clinical N0 PTMCs revealed that the distribution of the number of suspicious features in these patients was similar to that of the N1b group.
Papillary thyroid microcarcinomas in young (<50 years) or male patients, with an upper lobe or subcapsular location, and with microcalcification have a higher risk of LCLN metastasis. Individualized management according to the number of these suspicious features may be needed for small thyroid nodules.
甲状腺微小乳头状癌(PTMC)预后良好,病程进展缓慢。然而,部分PTMC病程呈侵袭性,可发生侧颈部淋巴结(LCLN)转移或远处转移。本研究旨在评估与LCLN转移相关的PTMC术前特征。
本项采用巢式匹配病例对照设计的回顾性队列研究纳入了199例初次手术时发生LCLN转移的PTMC患者(N1b组)以及196例无任何淋巴结转移或疾病持续存在的PTMC患者作为对照(N0无疾病证据组);对原发肿瘤大小进行了匹配。
与N0无疾病证据组相比,N1b组患者更年轻(<50岁)且男性比例更高(分别为P = 0.002和P = 0.003)。术前颈部超声(US)检查显示,N1b组PTMC比N0无疾病证据组PTMC更常位于甲状腺上叶、被膜下区域且伴有微钙化(所有P < 0.001)。这些特征数量的增加与LCLN转移风险较高显著相关(P < 0.001)。对26例临床N0期PTMC初始治疗后确诊为LCLN复发患者的临床及术前US特征进行评估,结果显示这些患者可疑特征数量的分布与N1b组相似。
年龄<50岁或男性、位于上叶或被膜下且伴有微钙化的甲状腺微小乳头状癌发生LCLN转移的风险较高。对于甲状腺小结节,可能需要根据这些可疑特征的数量进行个体化管理。